CCR4-dependent regulatory T cell function in inflammatory bowel disease

被引:111
|
作者
Yuan, Qian
Bromley, Shannon K.
Means, Terry K.
Jones, Krister J.
Hayashi, Fumitaka
Bhan, Atul K.
Luster, Andrew D. [1 ]
机构
[1] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Immunol & Inflammatory Dis,Div Rheumatol A, Boston, MA 02114 USA
[2] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Pediat,Div Pediat Gastroenterol & Nutr, Boston, MA 02114 USA
[3] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Pathol, Boston, MA 02114 USA
来源
JOURNAL OF EXPERIMENTAL MEDICINE | 2007年 / 204卷 / 06期
关键词
D O I
10.1084/jem.20062076
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Inflammatory bowel disease (IBD) is an idiopathic inflammatory disease of the intestine. CD4(+) T lymphocytes play an important role in both initiating and regulating intestinal inflammatory immune responses. CD4(+) CD25(+)CD45RB(low) regulatory T (T reg) cells are capable of preventing the development of colitis in a mouse model of IBD. The precise mechanism of T reg cell - mediated prevention of colitis in this model is unclear, and the role of chemokine receptors in the trafficking and function of T reg cells in this model has not been determined. We examined the role of the chemokine receptor CCR4 in in vivo trafficking and suppressive function of T reg cells in a mouse adoptive transfer model of IBD. CCR4-deficient T reg cells failed to accumulate in the mesenteric lymph nodes (MLNs) at early time points (2 - 5 d) after adoptive transfer, resulting in a failure to suppress the generation of pathogenic T cells and the development of colitis. Moreover, although CCR4-deficent T cells had equivalent in vitro suppressive activity and accumulated in MLNs at later time points (42 - 56 d), they were unable to suppress colitis. Our study demonstrates that CCR4 plays an important role in T reg cell trafficking in LNs and that this is critical for T reg cell suppressive function in vivo.
引用
收藏
页码:1327 / 1334
页数:8
相关论文
共 50 条
  • [21] Targeting Smads to Restore Transforming Growth Factor-β Signaling and Regulatory T-Cell Function in Inflammatory Bowel Disease
    Nguyen, Deanna D.
    Snapper, Scott B.
    GASTROENTEROLOGY, 2009, 136 (04) : 1161 - 1164
  • [22] Inflammatory effects of galectin-1-deficient regulatory T cells in a T cell transfer model of inflammatory bowel disease
    Lopez-Santalla, M.
    Escribano, O.
    Bueren, J.
    Garin, M. I.
    HUMAN GENE THERAPY, 2013, 24 (12) : A43 - A43
  • [23] Regulatory T-cell therapy for inflammatory bowel disease: more questions than answers
    Himmel, Megan E.
    Yao, Yu
    Orban, Paul C.
    Steiner, Theodore S.
    Levings, Megan K.
    IMMUNOLOGY, 2012, 136 (02) : 115 - 122
  • [24] CD44act as a marker for T cell regulatory activity in inflammatory bowel disease
    Estess, Pila
    Shah, Rajesh
    Siegelman, Mark
    JOURNAL OF IMMUNOLOGY, 2010, 184
  • [25] CD4 T-cell differentiation and inflammatory bowel disease
    Zenewicz, Lauren A.
    Antov, Andrey
    Flavell, Richard A.
    TRENDS IN MOLECULAR MEDICINE, 2009, 15 (05) : 199 - 207
  • [26] Vitamin D Inhibits Pro-Inflammatory T Cell Function in Patients With Inflammatory Bowel Disease
    Schardey, Josefine
    Globig, Anna-Maria
    Janssen, Christine
    Hofmann, Maike
    Manegold, Philipp
    Thimme, Robert
    Hasselblatt, Peter
    JOURNAL OF CROHNS & COLITIS, 2019, 13 (12): : 1546 - 1557
  • [27] SUPPRESSOR T-CELL FUNCTION IN INFLAMMATORY BOWEL-DISEASE - PROBLEMS AND PITFALLS
    BOIRIVANT, M
    FAIS, S
    PALLONE, F
    ITALIAN JOURNAL OF GASTROENTEROLOGY, 1985, 17 (05): : 285 - 286
  • [28] Induced and Natural Regulatory T Cells in the Development of Inflammatory Bowel Disease
    Mayne, Christopher G.
    Williams, Calvin B.
    INFLAMMATORY BOWEL DISEASES, 2013, 19 (08) : 1772 - 1788
  • [29] Regulatory T cells as potential targets for immunotherapy in inflammatory bowel disease
    Strisciuglio, Caterina
    van Deventer, Sander
    IMMUNOTHERAPY, 2010, 2 (06) : 749 - 752
  • [30] Regulatory T cell function in autoimmune disease
    Rajendeeran, Anandi
    Tenbrock, Klaus
    JOURNAL OF TRANSLATIONAL AUTOIMMUNITY, 2021, 4